Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular Diseases
暂无分享,去创建一个
B. H. Migdalof | K.L. Duchin | D.N. McKinstry | A.I. Cohen | B.H. Migdalof | K. Duchin | D. McKINSTRY | A. Cohen | D. McKinstry
[1] Y. Imai,et al. Determination of captopril in human blood by high-performance liquid chromatography with electrochemical detection. , 1982, Journal of chromatography.
[2] S. Singhvi,et al. Disposition of captopril in normal subjects , 1980, Clinical pharmacology and therapeutics.
[3] E. Ivashkiv,et al. Identification and determination of the S-methyl metabolite of captopril in human plasma by selected-ion monitoring gas chromatography-mass spectrometry. , 1984, Journal of pharmaceutical sciences.
[4] R. Poet,et al. Sequential electrochemical reduction, solvent partition, and automated thiol colorimetry for urinary captopril and its disulfides. , 1982, Journal of pharmaceutical sciences.
[5] P. Jocelyn. Biochemistry of the SH group , 1972 .
[6] R. Pedrinelli,et al. Influence of food on acute and chronic effects of captopril in essential hypertensive patients. , 1985, Journal of cardiovascular pharmacology.
[7] J. M. Shaw,et al. Effect of Food on the Bioavailability of Captopril in Healthy Subjects , 1982, Journal of clinical pharmacology.
[8] B. H. Migdalof,et al. Biotransformation of the disulfide of captopril in subcellular fractions of rat tissues. , 1982, Drug metabolism and disposition: the biological fate of chemicals.
[9] C. Edwards,et al. Intravenous captopril treatment in patients with severe cardiac failure. , 1986, British heart journal.
[10] M. Hisaoka,et al. Determination of captopril in blood and urine by high-performance liquid chromatography. , 1981, Chemical & pharmaceutical bulletin.
[11] C. Edwards,et al. Development and optimisation of a radioimmunoassay for plasma captopril. , 1983, Clinica chimica acta; international journal of clinical chemistry.
[12] E. Ivashkiv,et al. Determination of total captopril in human plasma by gas chromatography-mass spectrometry with selected-ion monitoring after reduction of disulfides. , 1984, Journal of pharmaceutical sciences.
[13] B. H. Migdalof,et al. In vitro biotransformations of [14C]captopril in the blood of rats, dogs and humans. , 1981, Biochemical pharmacology.
[14] H. Cheung,et al. Design of new antihypertensive drugs: potent and specific inhibitors of angiotensin-converting enzyme. , 1978, Progress in cardiovascular diseases.
[15] W. Louis,et al. High-performance liquid chromatographic analysis of captopril in plasma. , 1981, Journal of pharmaceutical sciences.
[16] E. Ivashkiv. Spectrofluorometric determination of captopril plus captopril disulfide metabolites in plasma. , 1984, Journal of pharmaceutical sciences.
[17] K. Iseki,et al. Captopril (SQ 14225) clearance during hemodialysis treatment. , 1981, Clinical nephrology.
[18] R. Fruncillo,et al. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives , 2004, European Journal of Clinical Pharmacology.
[19] S. Singhvi,et al. Thin-Layer Radiochromatographic Determination of Captopril (SQ 14,225) and its Disulfide Dimer Metabolite in Blood , 1980 .
[20] E. Frohlich,et al. Review of the overall experience of captopril in hypertension. , 1984, Archives of internal medicine.
[21] P. Plouin,et al. Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients. , 1984, British journal of clinical pharmacology.
[22] A. Breckenridge,et al. Drug protein conjugates--I. A study of the covalent binding of [14C]captopril to plasma proteins in the rat. , 1982, Biochemical pharmacology.
[23] R. Mäntylä,et al. Impairment of captopril bioavailability by concomitant food and antacid intake. , 1984, International journal of clinical pharmacology, therapy, and toxicology.
[24] E. Nickoloff,et al. A radioimmunoassay for total captopril in human serum or plasma samples. , 1984, Therapeutic drug monitoring.
[25] O. Drummer,et al. Demonstration of a S-methyl metabolite of captopril in patients undergoing chronic captopril therapy. , 1982, Clinical and experimental pharmacology & physiology. Supplement.
[26] O. Drummer,et al. Combined gas chromatographic-mass spectrometric procedure for the measurement of captopril and sulfur-conjugated metabolites of captopril in plasma and urine. , 1984, Journal of chromatography.
[27] P. Padfield,et al. ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: PAST, PRESENT, AND BRIGHT FUTURE , 1985, The Lancet.
[28] J. Giudicelli,et al. Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients. , 1984, British journal of clinical pharmacology.
[29] B. Workman,et al. The pharmacokinetics of captopril and captopril disulfide conjugates in uraemic patients on maintenance dialysis: Comparison with patients with normal renal function , 2004, European Journal of Clinical Pharmacology.
[30] W. Creasey,et al. Pharmacokinetics of Captopril in Elderly Healthy Male Volunteers , 1986, Journal of clinical pharmacology.
[31] M. Malley,et al. Gas chromatography/selected ion monitoring mass spectrometric determination of captopril in human blood. , 1980, Analytical chemistry.
[32] N. Hollenberg,et al. Accentuated vascular and endocrine response to SQ 20881 in hypertension. , 1977, The New England journal of medicine.
[33] R. Cody,et al. Clinical Pharmacokinetics of the Angiotensin Converting Enzyme Inhibitors , 1985, Clinical pharmacokinetics.
[34] E. Ivashkiv,et al. Determination of captopril in human blood and urine by GLC-selected ion monitoring mass spectrometry after oral coadministration with its isotopomer. , 1982, Journal of pharmaceutical sciences.
[35] C. Edwards,et al. Plasma free captopril concentrations during short and long term treatment with oral captopril for heart failure. , 1985, British heart journal.
[36] S. Singhvi,et al. Renal handling of captopril: Effect of probenecid , 1982, Clinical pharmacology and therapeutics.
[37] J. Cohn,et al. Role of the Renin-Angiotensin System in the Systemic Vasoconstriction of Chronic Congestive Heart Failure , 1978, Circulation.
[38] P. Fleiss,et al. Captopril in Human Blood and Breast Milk , 1981, Journal of clinical pharmacology.
[39] S. Podolsky,et al. Contribution of Prostaglandins to the Antihypertensive Action of Captopril in Essential Hypertension , 1981, Hypertension.
[40] J. R. Knill,et al. Captopril in the treatment of the elderly hypertensive patient. , 1985, Archives of internal medicine.
[41] J. Izzo,et al. Captopril reduces urinary cystine excretion in cystinuria. , 1987, Archives of internal medicine.
[42] D. Perrett,et al. The Determination of Captopril in Physiological Fluids Using High Perf Ormance Liquid Chromatography With Electrochemical Detection , 1982 .
[43] H. Kinoshita,et al. Enzyme immunoassay for captopril. , 1986, Journal of pharmaceutical sciences.
[44] H. Ono,et al. Determinatin of captopril in biological fluids by gas-liquid chromatography , 1980 .
[45] O. Drummer,et al. The disposition and metabolism of captopril , 1986, Medicinal research reviews.
[46] B Rubin,et al. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. , 1977, Science.
[47] S. Singhvi,et al. Quantitative determination of captopril in blood and captopril and its disulfide metabolites in plasma by gas chromatography. , 1984, Journal of pharmaceutical sciences.
[48] B. Karlberg,et al. Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake. , 1985, Journal of cardiovascular pharmacology.
[49] S. Singhvi,et al. Elimination kinetics of captopril in patients with renal failure. , 1984, Kidney international.
[50] T. Ito,et al. Determination of captopril and its disulphide in biological fluids. , 1982, Journal of chromatography.
[51] J. Unsworth,et al. Enalapril in the treatment of hypertension associated with impaired renal function. , 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[52] G. Dreslinski,et al. Captopril in hypertension; seven years later. , 1985, Journal of cardiovascular pharmacology.
[53] M. Cadilhac,et al. Cimetidine does not alter free unchanged captopril pharmacokinetics and biological effects in healthy volunteer. , 1986, Journal de pharmacologie.
[54] K. Kripalani,et al. Metabolism of captopril-L-cysteine, a captopril metabolite, in rats and dogs. , 1983, Xenobiotica; the fate of foreign compounds in biological systems.
[55] J. Cleland,et al. The effects of captopril on serum digoxin and urinary urea and digoxin clearances in patients with congestive heart failure. , 1986, American heart journal.
[56] O. Drummer,et al. Captopril disulfide conjugates may act as prodrugs: disposition of the disulfide dimer of captopril in the rat. , 1984, Biochemical pharmacology.
[57] K. Iseki,et al. Blood Concentration and Urinary Excretion of Captopril (SQ 14,225) in Patients with Chronic Renal Failure , 1981, Hypertension.
[58] R. Cody,et al. Captopril kinetics in chronic congestive heart failure , 1982, Clinical pharmacology and therapeutics.
[59] A. Sinaiko,et al. Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease. , 1983, The Journal of pediatrics.